Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-01-10

Clinical Trial Update: Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

View source ↗

Summary

A completed non-interventional study sponsored by AstraZeneca evaluates the real-world efficacy and use of quetiapine for acute schizophrenia episodes and maint…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED